| 证券代码：603067 | 证券简称：振华股份 公告编号：2025-034 | | --- | --- | | 债券代码：113687 | 债券简称：振华转债 | 湖北振华化学股份有限公司 关于可转债转股结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 累计转股情况：截至 2025 年 6 月 30 日，累计已有 239,000 元振华转债 转换为公司股份，累计转股股数为 20,687 股，占振华转债转股前公司已发行股 份总额的 0.0041%。 未转股可转债情况：截至 2025 年 6 月 30 日，振华转债尚未转股金额为 405,971,000 元，占可转债发行总量的 99.9412%。 本季度转股情况：振华转债自 2025 年 4 月 1 日至 2025 年 6 月 30 日期 间，转股的金额为 122,000 元，因转股形成的股份数量为 10,648 股，占振华转 债转股前公司已发行股份总额的 0.0021%。 一、可转债发行上市概况 （一）可转债发行情况 经中国证券监督管理委员 ...

Group 1 - The solid-state battery concept stocks are experiencing a partial rebound, with notable increases in share prices for several companies [1] - Transfar Technology (002866) has reached a daily limit increase, while China National Materials (002080) has risen over 8% [1] - Other companies such as Wanshun New Materials (300057), Zhenhua Holdings (603067), and Dadongnan (002263) have also seen their stock prices rise [1] Group 2 - There is a noticeable influx of dark pool funds into these stocks, indicating increased investor interest [1]

Group 1 - The company held its sixth meeting of the fifth board of directors on June 27, 2025, with all nine directors present, confirming the legality and validity of the meeting [1] - The board unanimously approved the proposal to amend the company's articles of association, with a voting result of 9 votes in favor, 0 against, and 0 abstentions [1] - The company will hold its first extraordinary general meeting of shareholders on July 15, 2025, at 14:00 to review the proposals submitted for shareholder approval, with the same voting result of 9 votes in favor, 0 against, and 0 abstentions [2]

湖北振华化学股份有限公司 章程 （2025 年 6 月修订） 目 录 第一章 总则 第二章 经营宗旨和范围 第三章 股份 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第四章 股东和股东会 第一节 股东 第二节 股东会的一般规定 第三节 股东会的召集 第四节 股东会的提案与通知 第五节 股东会的召开 第六节 股东会的表决和决议 第五章 董事会 第一节 董事 第二节 董事会 第六章 总经理及其他高级管理人员 第七章 财务会计制度、利润分配和审计 第一节 财务会计制度 第二节 内部审计 第三节 会计师事务所的聘任 第八章 通知与公告 第一节 通知 第二节 公告 第九章 合并、分立、增资、减资、解散和清算 第一节 合并、分立、增资和减资 第二节 解散和清算 第十章 修改章程 第十一章 附则 湖北振华化学股份有限公司章程 第一章 总则 第一条 为维护湖北振华化学股份有限公司（以下简称"公司"）、股东、职 工和债权人的合法权益，规范公司的组织和行为，根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券 法》"）和其他有关规定，制订本章程。 第二条 公司系依照 ...

Company Overview - Hubei Zhenhua Chemical Co., Ltd. is the only listed company in the chromium salt industry in China, with a design capacity of approximately 150,000 tons/year for sodium dichromate as of the end of 2024 [5][22] - The company achieved a production volume of approximately 260,000 tons for chromium salt series products in 2024, with plans to increase production to over 350,000 tons following the completion of the Chongqing production base relocation [5][22] Financial Performance - The company's total assets are projected to reach 517.5 billion yuan in 2025, with equity attributable to shareholders at 280.6 billion yuan [4] - The net profit for 2024 is expected to be 3.699 billion yuan, with a significant increase in operating income compared to previous years [4][14] - The company has maintained a stable gross profit margin of 26.41% in 2024, reflecting its strong market position and operational efficiency [14] Industry Dynamics - The chromium salt industry has seen an overall improvement in market conditions due to emerging demand and supply constraints, particularly in high-growth sectors such as aerospace and gas turbines [10][11] - The domestic chromium salt industry contributes approximately 45% of the global production, with Zhenhua Chemical accounting for over 60% of China's chromium salt capacity [11][12] - The industry is characterized by high barriers to entry due to environmental regulations, limiting the expansion of new production capacity [12] Raw Material Dependency - The company relies heavily on imported chromium ore, with approximately 80% sourced from South Africa, making it vulnerable to geopolitical risks and price fluctuations [6][12][18] - The price of chromium ore has increased by 11.63% year-on-year, while the price of soda ash has decreased by 23.27% due to market dynamics [20][18] Production and Cost Management - The company has optimized production costs through technological upgrades, achieving a reduction in processing costs for key products such as sodium dichromate and chromium oxides [19] - The company has implemented multiple price increases for its products in response to rising raw material costs, resulting in improved gross margins [19] Future Outlook - The company is focused on expanding its production capacity and enhancing its environmental compliance, with ongoing projects aimed at increasing production efficiency and product diversification [22][23] - The company is exploring new applications for chromium chemicals in emerging sectors, including energy storage, although the commercialization of these projects remains uncertain [23]

Core Viewpoint - The company, Hubei Zhenhua Chemical Co., Ltd., has maintained its credit rating of AA for both its corporate entity and its convertible bonds, with a stable outlook, as assessed by Zhongzheng Pengyuan Credit Rating Co., Ltd. [1][2] Group 1: Credit Rating Details - The previous credit rating results indicated that the company's corporate credit rating was AA and the credit rating for the convertible bonds, referred to as "Zhenhua Convertible Bonds," was also AA, with a stable outlook [1][2] - The current rating results show that the corporate credit rating remains AA and the credit rating for "Zhenhua Convertible Bonds" is still AA, with a stable outlook, indicating no change from the previous assessment [1][2]

Group 1 - The company, Hubei Zhenhua Chemical Co., Ltd., has issued convertible bonds totaling RMB 406.21 million, with a maturity of 6 years and a face value of RMB 100 per bond [3][4][19] - The bonds were approved by the Shanghai Stock Exchange and the China Securities Regulatory Commission, with the first issuance date on August 2, 2024 [3][4] - The company reported a revenue of RMB 406,671.94 million for 2024, representing a year-on-year increase of 9.95%, and a net profit of RMB 47,287.64 million, up 27.53% from the previous year [19][20] Group 2 - The bonds have a tiered interest rate structure, starting at 0.20% in the first year and increasing to 2.00% in the sixth year [4][5] - The initial conversion price for the bonds is set at RMB 11.64 per share, with provisions for adjustments based on corporate actions such as stock dividends and capital increases [6][8] - The company has established a dedicated fund management system for the raised capital, ensuring compliance with regulatory requirements and protecting investor interests [20][21] Group 3 - The company’s total assets increased by 18.98% year-on-year, reaching RMB 505,580.73 million by the end of 2024 [20] - The company’s net assets attributable to shareholders rose by 12.59% to RMB 315,899.40 million [20] - The company is engaged in the production and sale of chromium chemicals and related products, including sodium dichromate and potassium dichromate [19]

关于公开发行可转换公司债券 2025 年跟踪评级结 果的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 | 证券代码：603067 | 证券简称：振华股份 | 公告编号：2025-033 | | --- | --- | --- | | 债券代码：113687 | 债券简称：振华转债 | | 湖北振华化学股份有限公司 重要内容提示： 根据《上市公司证券发行管理办法》等相关规定，湖北振华化学股份有限公 司（以下简称"公司"）委托信用评级机构中证鹏元资信评估股份有限公司（以 下简称"中证鹏元"）对公司主体信用状况及 2024 年发行的可转换公司债券（转 债简称"振华转债"）进行了跟踪信用评级。 前次评级结果：公司主体信用等级为 AA，"振华转债"的信用等级为 AA，评级展望为稳定。 本次评级结果：公司主体信用等级为 AA，"振华转债"的信用等级为 AA，评级展望为稳定。 本次评级结果较前次没有变化。 董事会 2025 年 6 月 30 日 中证鹏元在对公司经营情况、财务状况等进行综合分析与评估的基础上，于 2025 年 ...

股票代码：603067 股票简称：振华股份 转债代码：113687 转债简称：振华转债 华泰联合证券有限责任公司 关于湖北振华化学股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 （2024 年度） 债券受托管理人 （深圳市前海深港合作区南山街道桂湾五路128号前海深港基金小镇B7栋401） 二〇二五年六月 重要声明 本报告依据《可转换公司债券管理办法》（以下简称"管理办法"）、《湖北振 华化学股份有限公司与华泰联合证券有限责任公司关于湖北振华化学股份有限 公司向不特定对象发行可转换公司债券之债券受托管理协议》（以下简称"受托 管理协议"）、《湖北振华化学股份有限公司向不特定对象发行可转换公司债券并 在主板上市募集说明书》（以下简称"募集说明书"）、《湖北振华化学股份有限公 司 2024 年年度报告》等相关公开信息披露文件、第三方中介机构出具的专业意 见等，由本期可转换公司债券受托管理人华泰联合证券有限责任公司（以下简称 "华泰联合证券"）编制。华泰联合证券对本报告中所包含的从上述文件中引述 内容和信息未进行独立验证，也不就该等引述内容和信息的真实性、准确性和完 整性做出任何保证或承担任何责任。 ...

信用评级报告声明 除因本次评级事项本评级机构与评级对象构成委托关系外，本评级机构及评级从业人员与评级对象不存 在任何足以影响评级行为独立、客观、公正的关联关系。 本评级机构与评级从业人员已履行尽职调查义务，有充分理由保证所出具的评级报告遵循了真实、客观、 公正原则，但不对评级对象及其相关方提供或已正式对外公布信息的合法性、真实性、准确性和完整性 作任何保证。 湖北振华化学股份有限公司相关 债项 2025 年跟踪评级报告 中鹏信评【2025】跟踪第【332】号 01 本评级机构依据内部信用评级标准和工作程序对评级结果作出独立判断，不受任何组织或个人的影响。 本评级报告观点仅为本评级机构对评级对象信用状况的个体意见，不作为购买、出售、持有任何证券的 建议。本评级机构不对任何机构或个人因使用本评级报告及评级结果而导致的任何损失负责。 本次评级结果自本评级报告所注明日期起生效，有效期为被评证券的存续期。同时，本评级机构已对受 评对象的跟踪评级事项做出了明确安排，并有权在被评证券存续期间变更信用评级。本评级机构提醒报 告使用者应及时登陆本公司网站关注被评证券信用评级的变化情况。 本评级报告版权归本评级机构所有，未经授权 ...